hrp0092p1-170 | Bone, Growth Plate and Mineral Metabolism (1) | ESPE2019
Kawamura Haruka
, Watanabe Satoshi
, I Takashi
, Asahina Izumi
, Moriuchi Hiroyuki
, Dateki Sumito
Introduction: Denosumab is an inhibitor of receptor activator of nuclear factor kappa-B ligand that strongly suppresses differentiation and function of osteoclasts. Cherubism is a rare autosomal dominant disorder characterized by symmetrical swelling of the mandible and the maxilla. In patients with cherubism, the bone is replaced by a fibrous granuloma containing multinucleated giant cells, which are differentiated into activated osteoclasts<p class="abst...